Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
3uaw | ADN | Purine nucleoside phosphorylase DeoD-type |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
3uaw | ADN | Purine nucleoside phosphorylase DeoD-type | / | 1.000 | |
3uay | ADN | Purine nucleoside phosphorylase DeoD-type | / | 0.708 | |
3uax | NOS | Purine nucleoside phosphorylase DeoD-type | / | 0.645 | |
1pr6 | XYA | Purine nucleoside phosphorylase DeoD-type | / | 0.622 | |
1pr0 | NOS | Purine nucleoside phosphorylase DeoD-type | / | 0.617 | |
4da6 | GA2 | Purine nucleoside phosphorylase DeoD-type | 2.4.2.1 | 0.610 | |
4da7 | AC2 | Purine nucleoside phosphorylase DeoD-type | 2.4.2.1 | 0.608 | |
1pke | 2FD | Purine nucleoside phosphorylase DeoD-type | / | 0.595 | |
1pr1 | FMB | Purine nucleoside phosphorylase DeoD-type | / | 0.588 | |
1pr5 | TBN | Purine nucleoside phosphorylase DeoD-type | / | 0.584 | |
1pk9 | 2FA | Purine nucleoside phosphorylase DeoD-type | / | 0.581 | |
1a69 | FMB | Purine nucleoside phosphorylase DeoD-type | / | 0.559 | |
1pr4 | MTP | Purine nucleoside phosphorylase DeoD-type | / | 0.557 | |
4da0 | GNG | Purine nucleoside phosphorylase DeoD-type | 2.4.2.1 | 0.556 | |
2isc | 223 | Purine nucleoside phosphorylase, putative | / | 0.546 | |
4dan | 2FA | Purine nucleoside phosphorylase DeoD-type | 2.4.2.1 | 0.544 | |
4ttj | FMC | Purine nucleoside phosphorylase DeoD-type | / | 0.544 | |
1k9s | FM1 | Purine nucleoside phosphorylase DeoD-type | / | 0.532 | |
2bsx | NOS | Purine nucleoside phosphorylase | / | 0.531 | |
4ts9 | FMC | Purine nucleoside phosphorylase DeoD-type | / | 0.525 | |
2i4t | UA2 | Purine nucleoside phosphorylase, putative | / | 0.518 | |
3occ | DIH | Purine nucleoside phosphorylase DeoD-type | / | 0.506 | |
1k9s | FM2 | Purine nucleoside phosphorylase DeoD-type | / | 0.505 | |
1jdz | FMB | Purine nucleoside phosphorylase | / | 0.501 | |
4da8 | BG2 | Purine nucleoside phosphorylase DeoD-type | 2.4.2.1 | 0.498 | |
3of3 | DIH | Purine nucleoside phosphorylase DeoD-type 1 | / | 0.487 | |
4a86 | H35 | Major pollen allergen Bet v 1-A | / | 0.484 | |
3fow | IMH | Purine nucleoside phosphorylase | / | 0.483 | |
4a87 | NAR | Major pollen allergen Bet v 1-A | / | 0.475 | |
3l9m | L9M | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.474 | |
3wv9 | FEG | Hmd co-occurring protein HcgE | / | 0.471 | |
1bk0 | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.467 | |
3o4r | NAP | Dehydrogenase/reductase SDR family member 4 | 1.1.1.184 | 0.467 | |
4b6u | M7G | Eukaryotic translation initiation factor 4E type 3 | / | 0.466 | |
1nqu | RDL | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.463 | |
2vbd | V10 | Isopenicillin N synthase | 1.21.3.1 | 0.462 | |
1hb1 | OCV | Isopenicillin N synthase | 1.21.3.1 | 0.460 | |
1hb3 | SCV | Isopenicillin N synthase | 1.21.3.1 | 0.460 | |
3p0f | BAU | Uridine phosphorylase 2 | 2.4.2.3 | 0.460 | |
3zoi | M2W | Isopenicillin N synthase | 1.21.3.1 | 0.459 | |
4e90 | 7RG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.459 | |
4ts3 | FMC | Purine nucleoside phosphorylase DeoD-type | / | 0.459 | |
2bu9 | HFV | Isopenicillin N synthase | 1.21.3.1 | 0.458 | |
3l9l | L9L | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.456 | |
3tda | PN0 | Cytochrome P450 2D6 | / | 0.455 | |
4ldl | XQC | Beta-2 adrenergic receptor | / | 0.455 | |
2bkt | RPF | Renin | 3.4.23.15 | 0.454 | |
2jb4 | A14 | Isopenicillin N synthase | 1.21.3.1 | 0.454 | |
2jdv | L20 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.454 | |
1jdt | MTA | Purine nucleoside phosphorylase | / | 0.453 | |
3gw9 | VNI | Lanosterol 14-alpha-demethylase | / | 0.452 | |
5bp9 | SAH | Putative methyltransferase protein | / | 0.452 | |
2ivp | ATP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.450 | |
3ox4 | NAD | Alcohol dehydrogenase 2 | 1.1.1.1 | 0.450 | |
2bi4 | NAD | Lactaldehyde reductase | 1.1.1.77 | 0.449 | |
5d6l | CAU | Beta-2 adrenergic receptor | / | 0.449 | |
1w06 | W05 | Isopenicillin N synthase | 1.21.3.1 | 0.448 | |
2cle | F6F | Tryptophan synthase alpha chain | / | 0.448 | |
2fs4 | PZ1 | Renin | 3.4.23.15 | 0.448 | |
1qiq | ACC | Isopenicillin N synthase | 1.21.3.1 | 0.447 | |
2ivi | ACW | Isopenicillin N synthase | 1.21.3.1 | 0.446 | |
1obn | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.445 | |
1pd9 | CO4 | Dihydrofolate reductase | 1.5.1.3 | 0.445 | |
1q0r | AKT | Aclacinomycin methylesterase RdmC | 3.1.1.95 | 0.444 | |
1xdd | AAY | Integrin alpha-L | / | 0.444 | |
3i5z | Z48 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.444 | |
4ktl | 1CQ | Cytochrome P450 | / | 0.444 | |
1pqc | 444 | Oxysterols receptor LXR-beta | / | 0.442 | |
3gc8 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.442 | |
4i4z | 2NE | 1,4-dihydroxy-2-naphthoyl-CoA synthase | / | 0.442 | |
3if9 | FAD | Glycine oxidase | 1.4.3.19 | 0.441 | |
3k3e | PDB | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.441 | |
4q71 | FAD | Bifunctional protein PutA | / | 0.441 | |
5c1m | CLR | Mu-type opioid receptor | / | 0.441 | |
4gbr | CAU | Beta-2 adrenergic receptor | / | 0.441 | |
1qjf | ACS | Isopenicillin N synthase | 1.21.3.1 | 0.440 | |
2g26 | 3LG | Renin | 3.4.23.15 | 0.440 |